IL1B and depressive symptom measurement: As noted in the “Introduction”, the association between high levels of baseline pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, and antidepressant treatment outcomes has been inconsistent in previous studies [10–17] despite widespread confidence in the role of inflammatory signaling in the pathogenesis of depression [1, 2].